Kinex Pharma makes clinical leadership appointments
This article was originally published in Scrip
Buffalo, New York-based Kinex Pharmaceuticals has appointed two key executives to its clinical leadership team. Dr Douglas Kramer, a former medical officer for the US FDA, joins the company as vice-president of clinical and regulatory affairs. Meanwhile Jane Devance, who previously worked at Schering-Plough (Merck), has been appointed director of clinical operations. They will both report directly to Kinex's chief medical officer Dr Rudolf Kwan.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.